Piper Sandler

The world leader in addiction treatment with 20 years of experience and a unique, patient-focused approach. They didn’t become the world leader in addiction treatment overnight. Their endeavor started small, with one singular focus – to intimately understand the journey of individuals suffering with addiction. People with addiction are often stereotyped and discounted, creating an environment where many are under-diagnosed, undertreated and under-supported. They’re often unaware of their treatment options, have limited access to treatment, or simply don’t seek it out because they’re afraid of being stigmatized.

Scientia Vascular, LLC is a medical device company based in Salt Lake City, Utah, founded in 2008. It specializes in the development, manufacture, and marketing of endovascular medical devices aimed at neuro, peripheral, and coronary vascular access applications. The company's flagship product, PLATO, is a micro-catheter designed for the treatment of hemorrhagic and ischemic strokes. By utilizing advanced micromachining and microfabrication processes, Scientia Vascular creates innovative devices that enhance performance for interventional specialists. The company is committed to improving patient outcomes by providing high-precision, minimally invasive solutions tailored to the evolving needs of healthcare providers.

Integrity Orthopaedics is a firm aiming to revolutionize soft tissue repair by enhancing initial repair strength and fostering an optimal healing environment. Their device focuses on immediate strength, minimal tendon mobility, broad points of fixation, and an optimal biologic environment.

Moxe Health specializes in facilitating the bi-directional exchange of clinical data between health plans and provider systems through its innovative clinical data integration platform. The company offers a range of services including risk adjustment, claims denial management, clinical summaries, administrative notifications, and care gap management. By creating an interactive network, Moxe ensures that health systems and health plans can share medical records and crucial patient insights quickly and efficiently, without disrupting clinicians' existing workflows. The platform supports the transition to value-based care by providing automated solutions that enhance access to essential information, allowing organizations to leverage their investments in population health and analytics effectively. Moxe's commitment to neutrality in data connectivity further enhances its value proposition in the healthcare industry.

Paragon 28, Inc. is a medical device company focused on developing and distributing surgical solutions for foot and ankle procedures. Established in 2010 and headquartered in Englewood, Colorado, with an additional location in Dublin, Ireland, the company offers a diverse range of products, including forefoot, midfoot, and hindfoot plates, screws, allograft bone systems, and various staples and nails. Its offerings address critical orthopedic needs, such as arthrodesis, hallux valgus corrections, and fracture fixation, encompassing nearly 80 product systems tailored to meet the specific requirements of patients and surgical procedures. The majority of its revenue is generated in the United States, reflecting its strong presence in the orthopedic implant marketplace.

Akoya Biosciences is a spatial biology company offering the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. The company has two industry-leading platforms that empower investigators and researchers to gain a deeper understanding of complex diseases such as cancer, and autoimmune or neurological disorders. The CODEX system is the only benchtop platform that can efficiently quantify more than 40 biomarkers and is ideally suited for biomarker discovery. The Phenoptics platform is the only end-to-end multiplexed immunofluorescence solution with the robustness and high throughput necessary for translational research and clinical trials.

Clinicient, Inc. is a technology company specializing in software solutions for outpatient rehabilitation clinics, particularly in the field of physical therapy. Founded in 1998 and headquartered in Portland, Oregon, Clinicient provides a range of products including TotalInsight, a comprehensive revenue cycle management solution that combines cloud-based electronic medical records (EMR) with outsourced billing services and data-driven coaching. Additionally, the company offers PracticeInsight, an integrated EMR and billing platform, along with InsightEMR, a customizable EMR tailored for therapy providers. Clinicient's services also encompass Medicare solutions, addressing functional limitation reporting and claims management. By streamlining patient registration, scheduling, clinical documentation, billing, and management reporting, Clinicient aims to enhance revenue optimization and reduce payment denials for its clients.

Sandler O’Neill + Partners is a full-service investment banking firm and broker-dealer focused on the financial services sector. Its clients include a wide variety of financial firms nationwide, and increasingly, around the globe. The firm provides the full suite of investment banking services, including merger and acquisition advisory, capital markets, fixed income and equity trading and sales, equity research, balance sheet management, mortgage finance and consulting services to financial institutions and their investors. Sandler O’Neill is a partnership, and different by design. Since the firm’s founding in 1988, its partners have sought to provide banks, thrifts and other financial services companies with an alternative to large Wall Street banking firms. The firm's focus has always been to enhance franchise value for clients within known, managed risk parameters. We provide clients a wealth of experience and knowledge more critical to them today than ever.

Elligo Health Research, Inc. is a healthcare organization focused on enhancing clinical research through innovative infrastructure and technology. Founded in 2016 and headquartered in Austin, Texas, the company facilitates the integration of clinical research into healthcare clinics, enabling faster development of pharmaceutical, biotechnology, and medical device products. By utilizing advanced health informatics and electronic health records, Elligo helps identify suitable patients for clinical trials and offers physicians the necessary support to conduct trials efficiently without the need for significant infrastructure investments. This approach not only accelerates patient enrollment and trial completion for sponsors but also allows patients to participate in clinical research within their own healthcare settings, minimizing logistical challenges and contributing to advancements in medical care. Additionally, Elligo empowers physicians with knowledge of emerging therapies, ultimately enhancing patient care and engagement in the research process.

Weeden & Co. is an employee-owned limited partnership. This structure allows all employees to participate in the success of the firm. Their success is wholly dependent upon listening to our clients, and upon delivering superior execution solutions. Their partnership fosters teamwork, loyalty, and a deep appreciation for each other and for our clients.

Foodsby LLC is an online marketplace based in Minneapolis, Minnesota, connecting office employees with local restaurants to facilitate convenient lunch deliveries. Founded in 2012, the platform allows individuals to place orders online, which are then aggregated for a single delivery from participating restaurants. This service aims to provide busy professionals with a diverse selection of meal options, promoting both variety and quality at reasonable prices. Foodsby partners with local and national restaurant brands to enhance the dining experience for employees, allowing them to enjoy satisfying meals without disrupting their workday.

Xenex is offering an effective approach to reducing the incidence of healthcare-associated infections. The Xenex mission is to save lives and reduce suffering by destroying deadly microorganisms that can cause hospital-acquired infections (HAIs). Xenex’s Pulsed Xenon Full Spectrum™ UV Disinfection Solution reduces the bacterial load often associated with an increased risk for HAIs. Since its commercial launch in June 2010, Xenex devices are now included in infection control protocols in almost three hundred hospitals throughout the U.S. Xenex was founded in 2009 and headquartered in San Antonio, Texas.

OrthoAccel Technologies, Inc. is a medical device company focused on developing, manufacturing, and selling innovative products for dental care and orthodontic treatment. The company is known for its AcceleDent Optima, an orthodontic device that enhances communication between patients and practices while monitoring tooth movement. Additionally, it offers AcceleDent Aura, which utilizes SoftPulse technology to deliver gentle micro pulses that promote bone remodeling. These devices include an activator, mouthpiece, USB extension cable with power adapter, and a travel case. OrthoAccel distributes its products through orthodontic practices both in the United States and internationally. Founded in 2006 and headquartered in Bellaire, Texas, the company aims to improve orthodontic outcomes and reduce treatment times through its advanced technologies.

Torax Medical, Inc. is a clinical-stage medical device company based in Shoreview, Minnesota, founded in 2002. The company specializes in developing and marketing innovative products aimed at restoring the barrier function of sphincters to treat various digestive diseases. Its primary offerings include LINX, a reflux management system designed for patients with gastroesophageal reflux disease (GERD), and FENIX, a continence restoration system for fecal incontinence. Utilizing specialized magnets, these devices facilitate minimally invasive procedures to address these conditions. Torax Medical operates in both the European and U.S. markets and is a subsidiary of Ethicon, Inc.

Norsk Titanium AS specializes in designing and manufacturing 3D-printed structural titanium production machinery, primarily for the aerospace sector. Utilizing its patented Rapid Plasma Deposition (RPD) technology, the company produces high-quality titanium components that are both cost-effective and efficient, reducing production costs by 50% to 75% compared to traditional manufacturing methods. Norsk Titanium's product lineup includes advanced machinery such as the MERKE IV and Gen-4 Machine, which cater to a diverse range of customers in aerospace, defense, and commercial industries, as well as the oil and gas sector. Founded in 2004 and headquartered in Hønefoss, Norway, the company also operates a product development and qualification center in Plattsburgh, New York. Norsk Titanium is a subsidiary of Scatec AS and is positioned for expansion into various high-complexity markets that require advanced titanium parts.

OrthoAccel Technologies, Inc. is a medical device company focused on developing, manufacturing, and selling innovative products for dental care and orthodontic treatment. The company is known for its AcceleDent Optima, an orthodontic device that enhances communication between patients and practices while monitoring tooth movement. Additionally, it offers AcceleDent Aura, which utilizes SoftPulse technology to deliver gentle micro pulses that promote bone remodeling. These devices include an activator, mouthpiece, USB extension cable with power adapter, and a travel case. OrthoAccel distributes its products through orthodontic practices both in the United States and internationally. Founded in 2006 and headquartered in Bellaire, Texas, the company aims to improve orthodontic outcomes and reduce treatment times through its advanced technologies.

Simmons & Company International is one of the largest and most experienced independent investment banks specializing in the energy industry, offering unparalleled M&A advisory, capital markets execution and investment research. By leveraging the collective knowledge of their growing team of approximately 150 professionals, they stay on the forefront of the industry's trends, drivers and developments and are also positioned to access the most strategic opportunities for their clients. Over the last four decades they have established theirselves as a premier partner in virtually every energy sector, serving a worldwide client base ranging from institutional investors, public and private companies and private equity firms. Their extensive market coverage and industry knowledge has not only profoundly shaped their unique perspective, but empowers clients to understand the energy sector in a new light.

GutCheck is an online qualitative market research platform that helps brands address critical business questions through agile market research. By leveraging innovative technologies and human experience intelligence, GutCheck enables clients to gain authentic insights into consumer behavior and preferences. This approach allows brands to make informed decisions throughout the innovation cycle, enhancing their ability to deliver better experiences at every customer touchpoint. GutCheck's services are designed to be quick, economical, and convenient, empowering clients to unlock new possibilities and respond effectively to market demands.

River Branch Holdings LLC, based in Chicago, Illinois, is an international merchant bank that provides a range of investment banking and investment management services. Founded in 2010, the firm specializes in mortgage banking, asset management, mergers and acquisitions advisory, and recapitalization, primarily serving the technology, financial services, and healthcare sectors. With over 100 years of combined expertise, River Branch Holdings emphasizes building long-term relationships with clients, investors, and stakeholders to deliver tailored solutions. The firm operates as a subsidiary of Piper Jaffray Companies, which acquired it to enhance its service offerings and market reach.

Lattice Engines, Inc. is a software company that specializes in providing predictive applications for marketing and sales organizations. Founded in 2006 and headquartered in San Mateo, California, the company offers a range of solutions including Lattice Atlas, which uses artificial intelligence to connect various data sources and build audiences, and Lattice for Salesforce, which delivers analytics and insights for sales teams. Other notable products include Lattice for Marketo, which enhances marketing programs with predictive insights, and predictive lead scoring tools designed to identify high-potential leads. The company also offers applications for executing personalized marketing campaigns and strategies for customer retention and expansion. Lattice Engines emphasizes the use of machine learning to drive efficient marketing and sales performance by integrating internal and external data. In addition to its software solutions, the company provides professional curriculum services and maintains a strategic partnership with Engagio Inc. Lattice Engines operates as a subsidiary of The Dun & Bradstreet Corporation.

SportsEngine, Inc. is a leading provider of web and mobile application software for managing youth, amateur, and professional sports. Founded in 2004 and headquartered in Minneapolis, Minnesota, the company offers a comprehensive suite of management tools designed to assist over 500,000 sports teams, leagues, clubs, and associations. Its product offerings include SportsEngine for team and tournament management, TeamUnify for swim team administration, GoMotion for class-based sports, Trackwrestling for wrestling event management, Tourney Machine for tournament organization, and RallyMe for fundraising. These tools help sports organizations streamline operations and improve communication among various stakeholders, including athletes, parents, coaches, and officials, thereby reducing administrative burdens and enhancing engagement in the sports community.

Edgeview Partners is a specialized investment bank serving the unique merger and acquisition (M&A) advisory needs of middle-market clients. Founded in 2001, our firm advises clients across the United States and Canada in virtually all industries, typically working with companies ranging in enterprise value from $25 million to $500 million. Our main focus is on the sale of privately held companies backed by entrepreneurs, families or private equity groups, as well as divisions of larger corporations. We also have extensive experience advising on growth capital raises, recapitalization transactions and buy-side acquisitions. Our qualified team of professionals has diverse expertise advising on middle-market mergers and acquisitions, having completed over 350 successful transactions throughout their careers. We combine senior-level commitment and significant resources to deliver unmatched client service. Our creativity and superior results for a broad spectrum of clients have been recognized with numerous industry awards, including recognition by The M&A Advisor as Boutique Investment Bank of the Year and multiple Deal of the Year awards.

Sapphire Digital is a health care technology company that provides solutions aimed at reducing the cost of care for consumers, employers, and health plans. The company offers an engagement and shopping platform that includes tools such as CareSelect for finding care and understanding costs, SmartShopper, which incentivizes employees to choose high-quality, cost-effective care, and MEG, providing quality scores for surgeons and facilities to aid in decision-making. Sapphire Digital also features Sapphire 360, which assists health plans in negotiating competitive rates and managing medical expenses through data and analytics. Founded in 2007 and based in Lyndhurst, New Jersey, with additional offices in New York, Oklahoma, and New Hampshire, the company serves over 280 million individuals annually, helping them make informed health care choices. Formerly known as Vitals, the company rebranded to Sapphire Digital in February 2019.

Oncolytics Biotech Inc. is a clinical-stage biopharmaceutical company based in Calgary, Canada, focused on developing innovative therapies for cancer treatment. Its primary product, pelareorep, is an immuno-oncology agent derived from reovirus, designed to enhance the immune system's ability to target and eliminate tumors, particularly those with an activated Ras pathway. The company has established collaboration agreements with Merck KGaA and Pfizer to explore the use of pelareorep in combination with other treatments for specific types of cancer, including hormone-receptor positive, human epidermal growth factor 2-negative metastatic breast cancer. In addition to pelareorep, Oncolytics Biotech is advancing other projects in its pipeline aimed at various cancers, including breast and gastrointestinal cancers. Founded in 1998, Oncolytics Biotech continues to seek novel approaches to address unmet medical needs in oncology.

Torax Medical, Inc. is a clinical-stage medical device company based in Shoreview, Minnesota, founded in 2002. The company specializes in developing and marketing innovative products aimed at restoring the barrier function of sphincters to treat various digestive diseases. Its primary offerings include LINX, a reflux management system designed for patients with gastroesophageal reflux disease (GERD), and FENIX, a continence restoration system for fecal incontinence. Utilizing specialized magnets, these devices facilitate minimally invasive procedures to address these conditions. Torax Medical operates in both the European and U.S. markets and is a subsidiary of Ethicon, Inc.

PerfectServe, Inc. is a provider of secure communication and collaboration solutions for the healthcare sector in the United States. Founded in 1999 and headquartered in Knoxville, Tennessee, the company offers a comprehensive platform that includes clinical communication, provider scheduling, nurse communication, and medical answering services. PerfectServe's tools facilitate effective interactions among physicians, nurses, and care teams, enhancing communication and coordination within healthcare settings. The platform is utilized by hospitals and physician practices across more than 130 markets, handling tens of thousands of daily interactions with approximately 12 million patients. With a strong focus on innovation, the company has seen significant growth, demonstrating a robust demand for its services that improve the accuracy and reliability of physician contact processes.

BioHorizons is committed to developing evidence-based and scientifically-proven products. This commitment started with the launch of the Maestro implant system in 1997 and remains in full force today with our most recent launches, the Tapered Plus and Tapered 3.0 implant systems. The focus of BioHorizons on science, innovation and service enables our customers to confidently use our comprehensive portfolio of dental implants and biologics products making BioHorizons one of the fastest growing companies in the dental industry.

Living Proof was created for the purpose of applying advanced technology to solve the toughest beauty challenges from a completely fresh perspective. They are a team of scientists from outside beauty, led by MIT Institute Professor Dr. Bob Langer, and beauty authorities with a shared vision: to invent efficient formulas based on entirely new molecules and breakthrough technologies for results you can see from across the room.

IDEV Technologies is a medical device company dedicated to developing innovative products for endovascular and interventional applications, particularly in the fields of interventional radiology, gastroenterology, vascular surgery, and cardiology. The company markets SUPERA, a unique self-expanding nitinol stent designed with a patented interwoven structure that enhances flexibility, radial strength, and resistance to kinking and crushing. SUPERA has received approval for treating biliary strictures in the United States. Additionally, IDEV is actively enrolling patients in the SUPERB IDE trial to evaluate the stent's safety and efficacy for use in the superficial femoral artery.

Advisory Research, Inc. is a privately owned investment management firm based in Chicago, Illinois, founded in 1974. The firm specializes in providing investment services to a diverse clientele, including high-net-worth individuals, institutions, endowments, foundations, corporations, and government entities. It manages separate client-focused equity portfolios and offers private funds, including equity mutual funds and hedge funds. Advisory Research primarily invests in value stocks across various market capitalizations, focusing on micro-cap, small-cap, mid-cap, and large-cap companies. The firm employs a fundamental analysis and bottom-up stock picking approach, conducting in-house research to inform its investment decisions. By delivering actively managed investment strategies and personalized client service, Advisory Research aims to achieve competitive risk-adjusted returns while fostering a collaborative culture among its investment professionals. The firm operates as a subsidiary of Ostara Inc.

Pandora Media, LLC is a music and podcast discovery platform based in Oakland, California, serving approximately 70 million users each month. Founded in 2000, Pandora utilizes its proprietary Music Genome Project and Podcast Genome Project technologies to deliver personalized music streaming services. Unlike traditional radio, which broadcasts the same content to all listeners, Pandora allows users to create customized stations and playlists, as well as search for and play songs on demand. The platform is accessible via mobile devices, web applications, and approximately 2,000 connected products in homes and vehicles. Pandora generates revenue through an ad-supported radio service, a subscription service called Pandora Plus, and an on-demand service known as Pandora Premium. By leveraging extensive listener data, Pandora enables targeted advertising for both local and national advertisers while providing artists with valuable insights to connect with their audience.

Vidacare Corporation, a medical device company, engages in the development, manufacture, and marketing of intraosseous access devices for diagnostic, monitoring, and therapeutic applications. The company provides EZ-IO Product System, which is designed to provide controlled vascular access through the intraosseous route to patients in emergent situations when vascular access is challenging and impossible. It also offers EZ-IO power driver, which is designed to penetrate the intraosseous space by drilling through the bone with a hollow needle and integrated stylet that doubles as the forward cutting bit to secure its correct placement; and EZ-IO Vascular Access Pack, a kit developed for emergency medical specialists to provide access to IV and IO devices to gain vascular access. In addition, the company provides a suite of hematology/oncology products, including a power driver and needle sets for bone marrow aspiration and biopsy; and OnControl, a bone marrow system for clinicians to perform bone marrow aspiration and biopsy procedures. Its products are used in pre-hospital, emergency, crash cart, and rapid response applications, as well as in military and homeland security industries. Vidacare Corporation was founded in 2001 and is headquartered in San Antonio, Texas.

Pandora Media, LLC is a music and podcast discovery platform based in Oakland, California, serving approximately 70 million users each month. Founded in 2000, Pandora utilizes its proprietary Music Genome Project and Podcast Genome Project technologies to deliver personalized music streaming services. Unlike traditional radio, which broadcasts the same content to all listeners, Pandora allows users to create customized stations and playlists, as well as search for and play songs on demand. The platform is accessible via mobile devices, web applications, and approximately 2,000 connected products in homes and vehicles. Pandora generates revenue through an ad-supported radio service, a subscription service called Pandora Plus, and an on-demand service known as Pandora Premium. By leveraging extensive listener data, Pandora enables targeted advertising for both local and national advertisers while providing artists with valuable insights to connect with their audience.

eFashionSolutions is the leading provider of online flagship stores to the branded fashion apparel/accessories, entertainment, and specialty retail industries. The eFashionSolutions e-commerce services are supported by a comprehensive technology platform. Services include buying and merchandising, design, photography, e-marketing, business intelligence, customer service, order management, and fulfillment functions. The Company is led by apparel and retail executives with extensive experience in merchandising, branding, customer service, and the technology solutions required to effectively manage and grow an online retail business. In 2006, eFashionSolutions was named to the Inc. 500 and NJ Finest 50. In 2007, the company received the USPS Strategic Business Development Award for their global shipping program, was named a finalist by the Extended Retail Institute in the Multi-Channel category, and received a Webby Award Nomination for DKNY.com. eFashionSolutions ships to over 120 countries internationally.

Pandora Media, LLC is a music and podcast discovery platform based in Oakland, California, serving approximately 70 million users each month. Founded in 2000, Pandora utilizes its proprietary Music Genome Project and Podcast Genome Project technologies to deliver personalized music streaming services. Unlike traditional radio, which broadcasts the same content to all listeners, Pandora allows users to create customized stations and playlists, as well as search for and play songs on demand. The platform is accessible via mobile devices, web applications, and approximately 2,000 connected products in homes and vehicles. Pandora generates revenue through an ad-supported radio service, a subscription service called Pandora Plus, and an on-demand service known as Pandora Premium. By leveraging extensive listener data, Pandora enables targeted advertising for both local and national advertisers while providing artists with valuable insights to connect with their audience.

RewardsPlus is a provider of benefits management technology. RewardsPlus' Benfinity system is a suite of Web-based applications and professional services designed to simplify and automate employee benefits communication, self-service enrollment and ongoing post-enrollment administration. Serving many nationally recognized corporations such as Unilever, AT&T, and National City Corporation.

Suros Surgical Systems, Inc. is a medical device manufacturer based in Indiana, specializing in minimally invasive methods for tissue excision and biopsy across various surgical specialties. The company is known for its patented ATEC™ (Automated Tissue Excision and Collection) system, which has advanced vacuum-assisted diagnostic breast biopsy techniques. Notably, Suros is the only provider of a commercially available MRI-guided vacuum-assisted breast biopsy system, facilitating early diagnosis for women in high-risk populations without the need for surgery. Suros also offers innovative needle options, including a 9 gauge petite needle for smaller breasts and a 12 gauge needle, which is recognized for its efficiency in performing breast biopsies. The ATEC™ system emphasizes improvements in speed, reliability, safety, and ease of use, allowing outpatient procedures with reduced pain, trauma, and recovery time. Suros is committed to advancing its technology and enhancing patient care through innovative solutions in tissue excision across various clinical applications.

Axya Medical is a U.S.-based company that offers knotless fixation systems for shoulder repair. The company provides knotless fixation systems, including control unit, handpiece, wielding sleeve, and sutures; and implants, including titanium implants, bioabsorbable implants, and super implants. Axya Medical also provides shoulder accessories such as removal tool, bone punch, bioabsorbable anchor tap, and drill guide with obturator; and general accessories, such as electrical cord, handpiece sterilization tray, protective horn sheath, suture separator, suture grasper, and arthroscopic suture cutter. It was founded in 1996 and is headquartered in Beverly, Massachusetts.

FieldCentrix specializes in mobile field service automation solutions that enhance service lifecycle management. Founded in 1994 and headquartered in Irvine, California, the company provides its FieldCentrix Enterprise management solution to streamline manual processes and integrate various applications related to field service. Its offerings cater to diverse sectors, including manufacturing, industrial equipment, medical devices, high technology, and real estate services. FieldCentrix's application suite connects processes, personnel, parts, and data, leveraging wireless communications, handheld devices, and internet technology to deliver efficient workflows and real-time information. As of 2005, FieldCentrix operates as a subsidiary of Astea International Inc.

InSound Medical, Inc., a privately held, venture-backed company based in Newark, California, develops and manufactures next-generation hearing solutions. Major investors include Johnson & Johnson, DeNovo Ventures, CMEA Ventures, and Psilos Group Managers, LLC.

Insulet Corporation is a medical device company dedicated to improving the lives of individuals with insulin-dependent diabetes through its innovative Omnipod System. Founded in 2000 and headquartered in Acton, Massachusetts, Insulet develops, manufactures, and markets an insulin delivery system that includes a tubeless, disposable insulin infusion device and a handheld personal diabetes manager. The Omnipod System is designed for ease of use, allowing for automated cannula insertion and smartphone control for dosage management. Insulet primarily sells its products through independent distributors, pharmacy channels, and directly to patients in the United States, Canada, Europe, and the Middle East. Since receiving FDA approval in 2005, the Omnipod System has been adopted by approximately 425,000 insulin-dependent diabetics worldwide, reflecting the company's commitment to enhancing diabetes management.

PHT is a leading provider of electronic patient reported outcome (ePRO) solutions utilized in clinical trials globally. The company offers advanced technologies, including the LogPad and StudyPad systems, which enhance data quality and support efficient data capture and management. PHT's StudyWorks online portal grants study sponsors, monitors, and sites real-time access to critical trial data, facilitating informed decision-making. By partnering with biopharmaceutical and medical device companies, PHT enables more effective and accurate clinical studies, ultimately contributing to the success of trials.

LipoScience is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile® test, measures the number of low density lipoprotein particles (LDL-P) in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. To date, over 8 million NMR LipoProfile tests have been ordered.

InSound Medical, Inc., a privately held, venture-backed company based in Newark, California, develops and manufactures next-generation hearing solutions. Major investors include Johnson & Johnson, DeNovo Ventures, CMEA Ventures, and Psilos Group Managers, LLC.

ZettaCom, Inc. manufactures and supplies chipset solutions to core multi-service switch and router original equipment manufacturers (OEMs).

Eunoe, Inc. is a San Francisco Bay-area medical device company focused on the treatment of neurological disorders through the management of cerebrospinal fluid.

Dynavax Technologies Corporation is a biopharmaceutical company based in Emeryville, California, focused on developing and commercializing innovative vaccines. The company's primary product, HEPLISAV-B, is an approved hepatitis B vaccine designed to prevent infection from all known subtypes of the virus in adults aged 18 and older. Dynavax is also advancing its proprietary CpG 1018 adjuvant to enhance vaccine efficacy and is engaged in various collaborations aimed at developing adjuvanted vaccines for COVID-19, pertussis, and universal influenza. In addition to its commercial efforts, Dynavax is involved in research partnerships with organizations such as Clover Biopharmaceuticals, the University of Queensland, and the Coalition for Epidemic Preparedness Innovations to create new vaccine candidates. The company was originally founded in 1996 as Double Helix Corporation and rebranded to its current name in September 1996.

Broncus Medical is a medical technology company specializing in the development of minimally-invasive devices for treating lung diseases, particularly emphysema. The company is known for its Exhale product line, which features the patented Airway Bypass technique, potentially being the first minimally-invasive procedure for homogeneous emphysema, a common form of the disease affecting many patients. Broncus is actively enrolling participants in its pivotal EASE Trial to evaluate this innovative treatment for severe homogeneous emphysema. In addition to its emphysema-focused efforts, Broncus operates within the interventional pulmonology sector, offering a range of products designed to enhance the diagnosis and treatment of lung conditions, including lung cancer and chronic obstructive pulmonary disease (COPD). The company is headquartered in Mountain View, California, with an international presence in Nyon, Switzerland.

Standard BioTools, previously known as Fluidigm, is driven by a bold vision – unleashing tools to accelerate breakthroughs in human health. Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the Company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies that help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy.

PHT is a leading provider of electronic patient reported outcome (ePRO) solutions utilized in clinical trials globally. The company offers advanced technologies, including the LogPad and StudyPad systems, which enhance data quality and support efficient data capture and management. PHT's StudyWorks online portal grants study sponsors, monitors, and sites real-time access to critical trial data, facilitating informed decision-making. By partnering with biopharmaceutical and medical device companies, PHT enables more effective and accurate clinical studies, ultimately contributing to the success of trials.

Oresis Communications designs and develops switching systems for carrying voice and data signals on the same telecommunications network. It offers ISIS-700 OmniService Switch, which enables carriers and service providers to migrate circuit and packet switched networks to a single backbone; and ISIS-700 Integrated OmniService Switch, which is a multiservice switch equipment that switches multiple voice, data, Internet, and video services in a single system. The company is based in Beaverton, Oregon.

Chameleon Systems is a privately held fabless semiconductor company that designs, markets and sells programmable system-on-a-chip solutions for the communications electronics markets. Headquartered in San Jose, California, the company has developed the industry´s first reconfigurable communications processor (RCP)--an ideal solution for data-intensive Internet, DSP, wireless basestations, voice compression, software-defined radio, and other high-performance embedded telecom and datacom applications. The Chameleon RCP solution allows data and telecom equipment vendors to create customized communications signal processors to increase performance and channel count, more quickly adapt to new requirements and standards, reduce time-to-market, lower development costs and reduce risk.

Lara Networks is a fabless semiconductor manufacturer specializing in the design, development, and marketing of memory-intensive application-specific integrated circuits (ASICs) tailored for the networking and communications sectors. The company focuses on creating silicon-based packet processing solutions aimed at enhancing wide area network (WAN) infrastructure equipment. Additionally, Lara Networks provides network search engines that facilitate efficient data processing within network systems.

PHT is a leading provider of electronic patient reported outcome (ePRO) solutions utilized in clinical trials globally. The company offers advanced technologies, including the LogPad and StudyPad systems, which enhance data quality and support efficient data capture and management. PHT's StudyWorks online portal grants study sponsors, monitors, and sites real-time access to critical trial data, facilitating informed decision-making. By partnering with biopharmaceutical and medical device companies, PHT enables more effective and accurate clinical studies, ultimately contributing to the success of trials.

RewardsPlus is a provider of benefits management technology. RewardsPlus' Benfinity system is a suite of Web-based applications and professional services designed to simplify and automate employee benefits communication, self-service enrollment and ongoing post-enrollment administration. Serving many nationally recognized corporations such as Unilever, AT&T, and National City Corporation.

DynamicSoft provides carrier-class infrastructure software for packet-based wireline and wireless communications networks. The company's infrastructure solutions enable carriers and communications application service providers to deploy telephony applications and converged services over Internet protocol-based networks. Its dynamicsoft Service Engine allows mobile carriers to deliver voice and data services over packet network, as well as provides a migration path to various IP 3G network environments; supports various services, such as voice, multimedia messaging, instant messaging, and presence; and consolidates common functions, which include customer data storage, authentication, authorization, provisioning, and service interaction. The company was founded in 1998 and is based in East Hanover, New Jersey.

As per the transaction announced on April 21, 2008, Instill Corporation was acquired by iTradeNetwork, Inc. Instill Corporation provides spend intelligence solutions for the foodservice industry. It offers supply chain information services, which automates the collection of transactional and process-oriented data from its customers trading partners. The company also provides a suite of hosted applications that helps its customers in managing various business processes, including trade spend management, food spend management, quality and regulatory compliance, promotion management, procurement, food safety, and vendor and product management. It offers its solutions to foodservice manufacturers, operators, and distributors. Instill Corporation was founded in 1993 and is headquartered in San Mateo, California.

Lifespire was created in late 1999 through the merging of 2 companies: Vida Healthcare and inspiria.com. Vida Healthcare, formed in 1996, has worked with hundreds of oncology doctors, nurses and allied health professionals to improve cancer care. Lifespire Their vision is to improve care through shared knowledge. But what does that mean to you, the patient, and your circle of family and friends They serve? It means that They are giving you and the ones closest to you -- your circle of care -- a resource for gathering credible knowledge, support and understanding of your experience with cancer. Some of you may have known us when They were Vida Healthcare. In Their four years as Vida, They delivered clinical support and education services to over 4,000 people experiencing cancer. Now They're bringing that experience and understanding to you. They're doing this in partnership with companies committed to improving the treatment of cancer. And They're using Lifespire.com as Their forum for delivery.

RewardsPlus is a provider of benefits management technology. RewardsPlus' Benfinity system is a suite of Web-based applications and professional services designed to simplify and automate employee benefits communication, self-service enrollment and ongoing post-enrollment administration. Serving many nationally recognized corporations such as Unilever, AT&T, and National City Corporation.

Centromine offers a browser-based, internet-accessed, enterprise-wide software applications and services for the health care market. Its applications allow behavioral health care programs and providers to manage the delivery and associated quality and cost of services completely over the internet.

PHT is a leading provider of electronic patient reported outcome (ePRO) solutions utilized in clinical trials globally. The company offers advanced technologies, including the LogPad and StudyPad systems, which enhance data quality and support efficient data capture and management. PHT's StudyWorks online portal grants study sponsors, monitors, and sites real-time access to critical trial data, facilitating informed decision-making. By partnering with biopharmaceutical and medical device companies, PHT enables more effective and accurate clinical studies, ultimately contributing to the success of trials.

HeartStent is a cardiovascular device firm. It is a direct revascularization device intended for coronary artery disease patients currently treated with coronary artery bypass grafts.

Chameleon Systems is a privately held fabless semiconductor company that designs, markets and sells programmable system-on-a-chip solutions for the communications electronics markets. Headquartered in San Jose, California, the company has developed the industry´s first reconfigurable communications processor (RCP)--an ideal solution for data-intensive Internet, DSP, wireless basestations, voice compression, software-defined radio, and other high-performance embedded telecom and datacom applications. The Chameleon RCP solution allows data and telecom equipment vendors to create customized communications signal processors to increase performance and channel count, more quickly adapt to new requirements and standards, reduce time-to-market, lower development costs and reduce risk.